Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
BACKGROUND: Antidepressant prescribing is widespread. Nonetheless, response to antidepressants is variable. If it was possible to predict response to medication and thus tailor treatment accordingly, this would not only improve patient outcomes but may also have economic benefits. AIMS: To test the...
Principais autores: | Wiles, N, Mulligan, J, Peters, T, Cowen, P, Mason, V, Nutt, D, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Lewis, G |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registros relacionados
-
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
por: Thomas, L, et al.
Publicado em: (2008) -
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
por: O'Donovan Michael, et al.
Publicado em: (2008-05-01) -
Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
por: Wiles, N, et al.
Publicado em: (2014) -
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
por: Lewis, G, et al.
Publicado em: (2011) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
por: Crawford, A, et al.
Publicado em: (2014)